BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lovastatin
,
rs6983267
,
NEUROG3
,
Angiogenesis
,
Lung cancer
,
Leukocyte
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
c.390
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for c.390
Explore Curated Studies Results
Literature
Most Relevant Literature
New subtype of PCH1C caused by novel EXOSC8 variants in a 16-year-old Spanish patient.
A PITX2 splice-site mutation in a family with Axenfeld-Rieger syndrome leads to decreased expression…
Plasma and follicular fluid osteopontin levels during ovarian cycle and their correlation with folli…
Cernunnos defect in an Iranian patient with T- B+ NK+ severe combined immunodeficiency: A case repor…
Genetic variants and altered expression of SERPINF1 confer disease susceptibility in patients with o…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet
Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab
2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C
Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Pati…
Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatment…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ